Mendelian Randomization Study With Clinical Follow-Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension.
Elham AlhathliThomas Henry JulianZain Ul Abideen GirachAlfred Arthur Roger ThompsonChristopher J RhodesStefan GräfNiamh ErringtonMartin R WilkinsAllan LawrieDennis WangJohnathan Cooper-KnockPublished in: Journal of the American Heart Association (2024)
Our data present a method for study of the metabolome in the context of PAH, and suggests several candidates for further evaluation and translational research.